Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Overview of attention for article published in JAMA Oncology, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
twitter: 104 X users

facebook: 2 Facebook pages
googleplus: 1 Google+ user

Citations

dimensions_citation: 285 Dimensions

Readers on

mendeley: 173 Mendeley

Summary News Blogs X Facebook Google+ Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Medical World News: Clinical Updates

AJMC, 26 Feb 2018

Serum Protein Signature Predicts Survival in Patients With Melanoma Receiving Anti-PD-1 Therapy Jaime Rosenberg A pretreatment…

Immune response to ovarian cancer may predict survival - Healthcanal.com

Health Canal, 13 Oct 2017

Researchers led by the US Mayo Clinic and UNSW Sydney have found that patients with high-grade ovarian cancer showed the most…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.